Anoxia-induced changes in optimal substrate for peripheral nerve

Neuroscience

Volumn 284, Issue , 2015, Pages 653-667

  Stecker, M M ^a   Stevenson, M R ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Anoxia; Diabetes; Glucose; Ischemia; Nerve conduction; Peripheral nerve

Indexed keywords

FRUCTOSE; GLUCOSE; GLYCOGEN; LACTIC ACID; SORBITOL; 3 HYDROXYBUTYRIC ACID; ACETIC ACID DERIVATIVE; GALACTOSE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANOXIA; ARTICLE; CELL FUNCTION; CONCENTRATION RESPONSE; HYPERGLYCEMIA; METABOLIC PARAMETERS; NERVE FUNCTION; NERVE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PERIPHERAL NERVE; PROTEIN FUNCTION; RAT; SCHWANN CELL; ACTION POTENTIAL; ANIMAL; MALE; METABOLISM; NERVE CONDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SCIATIC NERVE; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE;

3-HYDROXYBUTYRIC ACID; ACETATES; ACTION POTENTIALS; ANIMALS; ANOXIA; FRUCTOSE; GALACTOSE; GLUCOSE; LACTIC ACID; MALE; NEURAL CONDUCTION; OXYGEN; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SORBITOL; TISSUE CULTURE TECHNIQUES;

EID: 84918572734     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.10.048     Document Type: Article

References (64)

1. Arun P., Ariyannur P.S., Moffett J.R., Xing G., Hamilton K., Grunberg N.E., Ives J.A., Namboodiri A.M. Metabolic acetate therapy for the treatment of traumatic brain injury. J Neurotrauma 2010, 27:293-298.
2. Baylor K., Stecker M.M. Peripheral nerve at extreme low temperatures 2: pharmacologic modulation of temperature effects. Cryobiology 2009, 59:12-18.
3. Bergbauer K., Dringen R., Verleysdonk S., Gebhardt R., Hamprecht B., Wiesinger H. Studies on fructose metabolism in cultured astroglial cells and control hepatocytes: lack of fructokinase activity and immunoreactivity in astrocytes. Dev Neurosci 1996, 18:371-379.
4. Bril V., Ono Y., Buchanan R.A. Sural nerve sorbitol in patients with diabetic sensorimotor polyneuropathy. Diabetes Care 2004, 27:1160-1163.
5. Brown A.M., Evans R.D., Black J., Ransom B.R. Schwann cell glycogen selectively supports myelinated axon function. Ann Neurol 2012, 72:406-418.
6. Brown A.M., Sickmann H.M., Fosgerau K., Lund T.M., Schousboe A., Waagepetersen H.S., Ransom B.R. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. J Neurosci Res 2005, 79:74-80.
7. Brown A.M., Tekkok S.B., Ransom B.R. Glycogen regulation and functional role in mouse white matter. J Physiol 2003, 549:501-512.
8. Brown A.M., Wender R., Ransom B.R. Metabolic substrates other than glucose support axon function in central white matter. J Neurosci Res 2001, 66:839-843.
9. Burelle Y., Lamoureux M.C., Peronnet F., Massicotte D., Lavoie C. Comparison of exogenous glucose, fructose and galactose oxidation during exercise using 13C-labelling. Br J Nutr 2006, 96:56-61.
10. Callaghan B.C., Little A.A., Feldman E.L., Hughes R.A. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012, 6:CD007543.
11. Cheng C., Edin N.F., Lauritzen K.H., Aspmodal I., Christoffersen S., Jian L., Rasmussen L.J., Pettersen E.O., Xiaoqun G., Bergersen L.H. Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells. Cell Oncol (Dordr) 2012, 35:217-227.
12. Collins M.P., Periquet-Collins I. Nonsystemic vasculitic neuropathy: update on diagnosis, classification, pathogenesis, and treatment. Front Neurol Neurosci 2009, 26:26-66.
13. Debernardi R., Pierre K., Lengacher S., Magistretti P.J., Pellerin L. Cell-specific expression pattern of monocarboxylate transporters in astrocytes and neurons observed in different mouse brain cortical cell cultures. J Neurosci Res 2003, 73:141-155.
14. Dienel G.A. Brain lactate metabolism: the discoveries and the controversies. J Cereb Blood Flow Metab 2012, 32:1107-1138.
15. Dringen R., Schmoll D., Cesar M., Hamprecht B. Incorporation of radioactivity from [14C]lactate into the glycogen of cultured mouse astroglial cells. Evidence for gluconeogenesis in brain cells. Biol Chem Hoppe Seyler 1993, 374:343-347.
16. Dyck P.J. Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture. Neurology 1989, 39:111-118.
17. Dyck P.J., Albers J.W., Andersen H., Arezzo J.C., Biessels G.J., Bril V., Feldman E.L., Litchy W.J., O'Brien P.C., Russell J.W. Diabetic Polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011, 27:620-628. on behalf of the Toronto Expert Panel on Diabetic Neuropathy.
18. Dyck P.J., Karnes J.L., O'Brien P., Okazaki H., Lais A., Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986, 19:440-449.
19. Dyck P.J., Norell J.E., Dyck P.J. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999, 53:2113-2121.
20. Gabbay K.H., O'Sullivan J.B. The sorbitol pathway. Enzyme localization and content in normal and diabetic nerve and cord. Diabetes 1968, 17:239-243.
21. Greene D.A., Winegrad A.I. In vitro studies of the substrates for energy production and the effects of insulin on glucose utilization in the neural components of peripheral nerve. Diabetes 1979, 28:878-887.
22. Halestrap A.P. Monocarboxylic acid transport. Compr Physiol 2013, 3:1611-1643.
23. Hermans G., Schrooten M., Van Damme P., Berends N., Bouckaert B., De Vooght W., Robberecht W., Van den Berghe G. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care 2009, 13:R5.
24. Hobson-Webb L.D., Austin S.L., Bali D.S., Kishnani P.S. The electrodiagnostic characteristics of Glycogen Storage Disease Type III. Genet Med 2010, 12:440-445.
25. Jurcovicova J. Glucose transport in brain - effect of inflammation. Endocr Regul 2014, 48:35-48.
26. Kellogg A.P., Pop-Busui R. Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress. Antioxid Redox Signal 2005, 7:1521-1529.
27. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice 1983, 672. F.A. Davis Co, Philadelphia.
28. Kunst C., Kliegman R., Trindade C. The glucose-galactose paradox in neonatal murine hepatic glycogen synthesis. Am J Physiol 1989, 257:E697-E703.
29. Landowne D., Ritchie J.M. On the control of glycogenolysis in mammalian nervous tissue by calcium. J Physiol 1971, 212:503-517.
30. Leppanen L., Stys P.K. Ion transport and membrane potential in CNS myelinated axons. II. Effects of metabolic inhibition. J Neurophysiol 1997, 78:2095-2107.
31. Li X., Han H., Hou R., Wei L., Wang G., Li C., Li D. Progesterone treatment before experimental hypoxia-ischemia enhances the expression of glucose transporter proteins GLUT1 and GLUT3 in neonatal rats. Neurosci Bull 2013, 29:287-294.
32. Lindstrom P., Brismar T. Mechanism of anoxic conduction block in mammalian nerve. Acta Physiol Scand 1991, 141:429-433.
33. Ludvigson M.A., Sorenson R.L. Immunohistochemical localization of aldose reductase. I. Enzyme purification and antibody preparation - localization in peripheral nerve, artery, and testis. Diabetes 1980, 29:438-449.
34. Maekawa K., Tanimoto T., Okada S., Suzuki T., Suzuki T., Yabe-Nishimura C. Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated from rat: effects of high glucose and osmotic stress. Brain Res Mol Brain Res 2001, 87:251-256.
35. Magnani P., Cherian P.V., Gould G.W., Greene D.A., Sima A.A., Brosius F.C. Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3. Metabolism 1996, 45:1466-1473.
36. Malthankar-Phatak G.H., Patel A.B., Xia Y., Hong S., Chowdhury G.M., Behar K.L., Orina I.A., Lai J.C. Effects of continuous hypoxia on energy metabolism in cultured cerebro-cortical neurons. Brain Res 2008, 1229:147-154.
37. Masoudi-Nejad A., Asgari Y. Metabolic cancer biology: structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment. Semin Cancer Biol 2014, [Epub ahead of print].
38. Meakin P.J., Fowler M.J., Rathbone A.J., Allen L.M., Ransom B.R., Ray D.E., Brown A.M. Fructose metabolism in the adult mouse optic nerve, a central white matter tract. J Cereb Blood Flow Metab 2007, 27:86-99.
39. Mikaeili H., Yazdchi M., Barazandeh F., Ansarin K. Euglycemic state reduces the incidence of critical illness polyneuropathy and duration of ventilator dependency in medical intensive care unit. Bratisl Lek Listy 2012, 113:616-619.
40. Orosz S.E., Townsend S.F., Tornheim P.A., Brownscheidle C.M. Localization of aldose reductase and sorbitol dehydrogenase in the nervous system of normal and diabetic rats. Acta Diabetol Lat 1981, 18:373-381.
41. Perez de Heredia F., Wood I.S., Trayhurn P. Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes. Pflugers Arch 2010, 459:509-518.
42. Pescador N., Villar D., Cifuentes D., Garcia-Rocha M., Ortiz-Barahona A., Vazquez S., Ordonez A., Cuevas Y., Saez-Morales D., Garcia-Bermejo M.L., Landazuri M.O., Guinovart J., del Peso L. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLoS One 2010, 5:e9644.
43. Ritchie J.M., Straub R.W. Oxygen consumption and phosphate efflux in mammalian non-myelinated nerve fibres. J Physiol 1980, 304:109-121.
44. Russell J.W., Berent-Spillson A., Vincent A.M., Freimann C.L., Sullivan K.A., Feldman E.L. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 2008, 30:420-429.
45. Sango K., Suzuki T., Yanagisawa H., Takaku S., Hirooka H., Tamura M., Watabe K. High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32. J Neurochem 2006, 98:446-458.
46. Schneider U., Niedermeier W., Grafe P. The paradox between resistance to hypoxia and liability to hypoxic damage in hyperglycemic peripheral nerves. Evidence for glycolysis involvement. Diabetes 1993, 42:981-987.
47. Semchyshyn H.M., Miedzobrodzki J., Bayliak M.M., Lozinska L.M., Homza B.V. Fructose compared with glucose is more a potent glycoxidation agent in vitro, but not under carbohydrate-induced stress in vivo: potential role of antioxidant and antiglycation enzymes. Carbohydr Res 2014, 384:61-69.
48. Smith G.I., Jeukendrup A.E., Ball D. Sodium acetate induces a metabolic alkalosis but not the increase in fatty acid oxidation observed following bicarbonate ingestion in humans. J Nutr 2007, 137:1750-1756.
49. Stecker M., Wolfe J., Stevenson M. Neurophysiologic responses of peripheral nerve to anoxia: effects of hypothermia and age. Clin Neurophysiol 2013, 124:801-808.
50. Stecker M., Wolfe J., Stevenson M. Neurophysiologic responses of peripheral nerve to repeated episodes of anoxia. Clin Neurophysiol 2013, 124:792-800.
51. Stecker M.M., Baylor K. Peripheral nerve at extreme low temperatures 1: effects of temperature on the action potential. Cryobiology 2009, 59:1-11.
52. Stecker M.M., Stevenson M. The effect of glucose concentration on peripheral nerve and its response to anoxia. Muscle Nerve 2013, 49:370-377.
53. Stewart M.A., Passonneau J.V., Lowry O.H. Substrate changes in peripheral nerve during ischaemia and Wallerian degeneration. J Neurochem 1965, 12:719-727.
54. Takebe K., Nio-Kobayashi J., Takahashi-Iwanaga H., Iwanaga T. Histochemical demonstration of a monocarboxylate transporter in the mouse perineurium with special reference to GLUT1. Biomed Res 2008, 29:297-306.
55. Tong H., Imahashi K., Steenbergen C., Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 2002, 90:377-379.
56. Ullah M.S., Davies A.J., Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006, 281:9030-9037.
57. Van den Berghe G., Wilmer A., Milants I., Wouters P.J., Bouckaert B., Bruyninckx F., Bouillon R., Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006, 55:3151-3159.
58. Vincent A.M., McLean L.L., Backus C., Feldman E.L. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 2005, 19:638-640.
59. Vincent A.M., Perrone L., Sullivan K.A., Backus C., Sastry A.M., Lastoskie C., Feldman E.L. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007, 148:548-558.
60. Walls A.B., Sickmann H.M., Brown A., Bouman S.D., Ransom B., Schousboe A., Waagepetersen H.S. Characterization of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) as an inhibitor of brain glycogen shunt activity. J Neurochem 2008, 105:1462-1470.
61. Wender R., Brown A.M., Fern R., Swanson R.A., Farrell K., Ransom B.R. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 2000, 20:6804-6810.
62. Wiesinger H., Hamprecht B., Dringen R. Metabolic pathways for glucose in astrocytes. Glia 1997, 21:22-34.
63. Wiesinger H., Thiess U., Hamprecht B. Sorbitol pathway activity and utilization of polyols in astroglia-rich primary cultures. Glia 1990, 3:277-282.
64. Zovein A., Flowers-Ziegler J., Thamotharan S., Shin D., Sankar R., Nguyen K., Gambhir S., Devaskar S.U. Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol 2004, 286:R273-R282.